Udac, Baby Boy .

HRN: 21-72-94  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/19/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/19/2022
08/25/2022
IVT
30
OD
PoTentially Septic Newborn
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: